Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8539
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorPejcic, Ana-
dc.contributor.authorIskrov G.-
dc.contributor.authorStefanov, Rumen-
dc.date.accessioned2020-09-19T16:01:47Z-
dc.date.available2020-09-19T16:01:47Z-
dc.date.issued2018-
dc.identifier.issn1473-7167-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8539-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceExpert Review of Pharmacoeconomics and Outcomes Research-
dc.titleAuthors’ reply to Rare diseases in Romania–a response to ‘Transposition and implementation of EU rare diseases policy in Eastern Europe’-
dc.typecontributionToPeriodical-
dc.identifier.doi10.1080/14737167.2018.1491143-
dc.identifier.scopus2-s2.0-85050238360-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

132

Downloads(s)

19

Files in This Item:
File Description SizeFormat 
10.1080-14737167.2018.1491143.pdf625.4 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons